Welcome to our dedicated page for CTAQW news (Ticker: CTAQW), a resource for investors and traders seeking the latest updates and insights on CTAQW stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect CTAQW's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of CTAQW's position in the market.
Carney Technology Acquisition Corp. II has announced its inability to finalize an initial business combination and will proceed with liquidation as per its Amended and Restated Certificate of Incorporation. Following a special meeting on December 14, 2022, stockholders approved an extension until June 14, 2023. However, the company concluded it could not deliver a satisfactory transaction, resulting in the decision to liquidate. As of February 14, 2023, the Class A common stock will be deemed cancelled, and holders will receive their proportional share from the trust account. The company will not redeem warrants, which will expire worthless.
Carney Technology Acquisition Corp. II (NASDAQ: CTAQ) announced the postponement of its special stockholders' meeting from December 13, 2022, to December 14, 2022, at 9:00 a.m. Eastern Time. The record date remains November 10, 2022. Stockholders can vote regardless of subsequent share sales. Additionally, the deadline for Class A common stock redemption is extended to December 12, 2022. To address uncertainties from the Inflation Reduction Act, the Sponsor will indemnify against excise tax liabilities and deposit $0.04 per non-redeemed share monthly until June 14, 2023.
Carney Technology Acquisition Corp. II (NASDAQ: CTAQ) announced it received a notice from Nasdaq due to its inability to timely file its Quarterly Report on Form 10-Q for Q1 2021. The company cited issues related to accounting for its outstanding warrants as liabilities. Nasdaq has given the company until July 27, 2021, to submit a compliance plan. If compliance is not regained, the company faces potential delisting. While trading is unaffected immediately, failure to file within the extended period could result in significant consequences.
Carney Technology Acquisition Corp. II (NASDAQ: CTAQU) announced holders of its initial public offering units may separately trade Class A common stock and warrants starting February 1, 2021. The Class A common stock will trade under the symbol 'CTAQ' and the warrants under 'CTAQW.' Units that are not separated will continue to trade as 'CTAQU.' This press release does not constitute an offer to sell or a solicitation for the securities of the Company in any state where such actions would be unlawful.
Carney Technology Acquisition Corp. II (NASDAQ: CTAQU) successfully closed its IPO on December 14, 2020, raising $402.5 million from the sale of 40,250,000 units priced at $10 each. The units consist of one Class A common stock share and one-third of a redeemable warrant, which is exercisable at $11.50. Trading under the ticker symbol ‘CTAQU’ began on December 10, 2020. The company aims to focus on mergers and acquisitions within the technology sector, with the proceeds placed in trust for future business combinations.
Carney Technology Acquisition Corp. II has priced its initial public offering (IPO) at $10.00 per unit, raising funds through 35 million units listed on Nasdaq under symbol CTAQU. Each unit includes one share of Class A common stock and one-third of a redeemable warrant. The IPO is managed by Morgan Stanley, Cantor Fitzgerald, and Mizuho Securities, with a 45-day option for underwriters to purchase an additional 5.25 million units. The company seeks to target mergers or acquisitions in the technology sector.
